Business Context and Reporting Period
This Form 6-K filing by Grupo Aval Acciones Y Valores S.A. covers the month of September 2015, with the report date of August 31, 2015. The filing serves to notify shareholders of upcoming corporate governance actions, specifically the convening of an extraordinary General Shareholders' meeting scheduled for September 7, 2015, and the planned ordinary meeting later in September.
Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a procedural notice regarding shareholder meetings and does not contain financial statements or performance data for the period ended June 30, 2015, other than referencing the intent to approve them.
Material Changes
No material financial changes are reported in this document. The primary material event is the proposed amendment to the company's by-laws. Specifically, the company seeks to add an interim paragraph to Article 14 to formalize the consideration and approval of consolidated financial statements for the period ended June 30, 2015.
Guidance, Outlook, and Management Commentary
- Extraordinary Meeting: Scheduled for September 7, 2015, at 3:00 p.m. at Banco de Bogotá S.A. in Bogotá D.C. The agenda focuses on the by-law amendment regarding consolidated financial statements.
- Ordinary Meeting: Management intends to call an ordinary General Shareholders' meeting during September. The purpose is to approve the separate (individual) financial statements for the period ended June 30, 2015, and to propose a distribution of dividends.
- Shareholder Action: Shareholders are instructed to file proxies at Deceval's offices or confirm attendance via phone to obtain certificates of assistance.
Key Facts for Investor Verification
- Verify the outcome of the by-law amendment at the September 7, 2015, extraordinary meeting.
- Confirm the specific date and dividend proposal details once the ordinary General Shareholders' meeting is officially summoned.
- Review the separate and consolidated financial statements for the period ended June 30, 2015, which are the subject of the upcoming approvals.
- Note that this filing contains no financial performance data; investors must refer to the actual financial statements for metrics.